Hematology TimesFDA approves biosimilar rituximab for NHLNovember 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesEC approves mogamulizumab for MF, SSNovember 28, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesASH expands late-breaking abstract sessionNovember 26, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesBiosimilar deemed equivalent to rituximab in FLNovember 21, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesElderly NHL patients have higher NRM after HSCTNovember 20, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesBortezomib may overcome resistance in WMNovember 19, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesQuick FDA approval for brentuximab vedotin in PTCLNovember 16, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesR-CHOP effective as first-line treatment in FLNovember 16, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesSelinexor on fast track for DLBCLNovember 8, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCombo appears safe, active in rel/ref NHLNovember 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesSandoz won’t seek U.S. approval for rituximab biosimilarNovember 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesHealth Canada approves pralatrexate for rel/ref PTCLNovember 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesEC approves venetoclax in combo with rituximabNovember 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesNovel risk factors for febrile neutropenia in NHL, other cancersNovember 1, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo can prolong overall survival in MCLOctober 25, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
